Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,538.70
(
-1.03%
)
US TECH 100
23,411.12
(
-1.31%
)
Dow Jones
45,781.18
(
-0.52%
)
Brent Oil
107.25
(
2.70%
)
Bitcoin
69,589.00
(
-0.44%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

swampboots

Send PM Follow Ignore
Followers 179
Posts 30024
Boards Moderated 3
Alias Born 07/09/2003

swampboots

Re: DewDiligence post# 157298

Sunday, 02/24/2013 2:43:23 PM

Sunday, February 24, 2013 2:43:23 PM

Post# of 257262
Brill says in article (Newsweek 7 month researched piece): Retuximab (Retuxan) 660 mg $13,500 for patient, maybe $3000-$3500 cost for Anderson....... Brill goes to long length to point out, those on Board of Anderson highly overpaid (article written by such a party in Washington Post)?
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today